Stock Research for AVMXY

AVMXY

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

AVMXY Stock Chart & Research Data

The AVMXY chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the AVMXY chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


AVMXY Due diligence Resources & Stock Charts

The AVMXY stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View AVMXY Detailed Price Forecast - CNN Money CNN View AVMXY Detailed Summary - Google Finance
Yahoo View AVMXY Detailed Summary - Yahoo! Finance Zacks View AVMXY Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View AVMXY Trends & Analysis - Trade-Ideas Barrons View AVMXY Major Holders - Barrons
NASDAQ View AVMXY Call Transcripts - NASDAQ Seeking View AVMXY Breaking News & Analysis - Seeking Alpha
Spotlight View AVMXY Annual Report - CompanySpotlight.com OTC Report View AVMXY OTC Short Report - OTCShortReport.com
TradeKing View AVMXY Fundamentals - TradeKing Charts View AVMXY SEC Filings - Bar Chart
WSJ View Historical Prices for AVMXY - The WSJ Morningstar View Performance/Total Return for AVMXY - Morningstar
MarketWatch View the Analyst Estimates for AVMXY - MarketWatch CNBC View the Earnings History for AVMXY - CNBC
StockMarketWatch View the AVMXY Earnings - StockMarketWatch MacroAxis View AVMXY Buy or Sell Recommendations - MacroAxis
Bullish View the AVMXY Bullish Patterns - American Bulls Short Pains View AVMXY Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View AVMXY Stock Mentions - StockTwits PennyStocks View AVMXY Stock Mentions - PennyStockTweets
Twitter View AVMXY Stock Mentions - Twitter Invest Hub View AVMXY Investment Forum News - Investor Hub
Yahoo View AVMXY Stock Mentions - Yahoo! Message Board Seeking Alpha View AVMXY Stock Mentions - Seeking Alpha






Financial & Transaction Holdings

SECform4 View Insider Transactions for AVMXY - SECform4.com Insider Cow View Insider Transactions for AVMXY - Insider Cow
CNBC View AVMXY Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for AVMXY - OTC Markets
Yahoo View Insider Transactions for AVMXY - Yahoo! Finance NASDAQ View Institutional Holdings for AVMXY - NASDAQ


Stock Charts

FinViz View AVMXY Stock Insight & Charts - FinViz.com StockCharts View AVMXY Investment Charts - StockCharts.com
BarChart View AVMXY Stock Overview & Charts - BarChart Trading View View AVMXY User Generated Charts - Trading View


Latest Financial News for AVMXY

AVITA Medical Announces Institutional Placement of A$16.0 Million to Support U.S. Commercialization of the RECELL® Device
Posted on Tuesday June 05, 2018

AVITA Medical (ASX: AVH, OTCQX: AVMXY), a regenerative medicine company with a technology platform positioned to address unmet medical needs in burns, chronic wounds, and aesthetics indications, today announced an institutional placement of A$16.0 million to prepare for the planned U.S. launch of the RECELL® Device in the treatment of severe burns. Avita has received commitments from international and Australian institutional and sophisticated investors for a placement of A$16.0 million at an issue price of A$0.050 per share, with the placement to occur in two tranches.


AVITA Medical Announces Presentation at ISPOR Meeting Validating Acute Burn Health Economic Model
Posted on Monday May 21, 2018

AVITA Medical (ASX: AVH, OTCQX: AVMXY) today announced that results from a study validating the predicted outcomes and costs from an acute burns health economic model were presented at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 23rd Annual International Meeting in Baltimore, Maryland. The landmark model is the first validated economic model available to assess the costs and clinical impact of new interventions versus standard of care for inpatient treatment of acute burns along the burn care continuum. The model demonstrates the ability to predict the cost-effectiveness, incremental costs and the budget impact of different care management approaches.


RECELL® Pivotal Trial in Third-Degree Burns Meets Co-Primary Endpoints and Shows Statistically Significant Reduction in Donor Skin Requirements
Posted on Sunday April 15, 2018

AVITA Medical today announced that its pivotal, controlled clinical trial in the treatment of deep full-thickness burns with the RECELL® Autologous Cell Harvesting Device achieved its co-primary endpoints, demonstrating a statistically significant reduction in donor skin requirements versus standard of care while achieving comparable definitive wound closure.


RECELL® Study in Facial Burns Shows Excellent Cosmetic Outcomes
Posted on Thursday April 12, 2018

AVITA Medical announced today results from a clinical study highlighting the potential benefits of the RECELL® Autologous Cell Harvesting Device in the treatment of deep partial-thickness facial burns.


Enter a stock symbol to view the stock details.